ACO roundup: MSSP linked to $655M in Medicare savings, according to NAACOS

Key accountable care news from the past week

  • 'Unquestionably good news': Why US health spending slowed for the second straight year. CMS actuaries say U.S. health care spending increased by 3.9% to $3.5 trillion in 2017, down from a growth rate of 4.3% in 2016. The actuaries attributed the slowdown in health spending growth to a reduction in the use and intensity of health-related goods and services, including hospital care, insurance, physician and clinical services, and retail prescription drugs.

  • NAACOS report says MSSP linked to $665M in Medicare savings. A new report released by the National Association of ACOs found that Medicare Shared Savings Program ACOs between 2013 and 2016 saved Medicare nearly $2.7 billion, or about $665.8 million after accounting for incentive payments. The findings counter a recent CMS report that found the program was linked to about $1.6 billion in savings—and that the ACOs were actually linked to a net loss of about $384 million once bonuses were accounted for. According to the latest report, the findings differ from CMS' calculations because CMS uses ACOs' annual spending target benchmarks to calculate their savings, rather than assessing savings by calculating how much additional spending there would be if ACOs did not exist.

  • HHS advisory committee approves new community oncology model. HHS' Physician-Focused Payment Model Technical Advisory Committee (PTAC) on Monday approved a new oncology care model that aims to curb spending and improve care quality. The model, called Making Accountable Sustainable Oncology Networks (MASON), would more accurately determine target medical home costs for oncology patients by using EHR data to identify the clinical criteria that cause certain groups of patients to incur higher costs. According to Barbara McAneny—president of the American Medical Association and CEO of Innovative Oncology Business Solutions, which proposed the MASON model—the more accurate target price estimates would help prevent oncologists from being penalized if they end up with groups of more costly patients, since previously, the costs were averaged across all patients.

From Advisory Board:

  • What you need to know about imaging CDS in 2019. Join us on today, December 13, at 3:00 p.m. ET to learn the latest on imaging clinical decision support (CDS). This session analyzes the Medicare requirements, as well as provides strategies to get the most of your CDS tool.

Register Here

Register Here

  • Examine Medicare's Hospital Inpatient Pay-for-Performance update, FY 2019. Join us on Thursday, January 24, at 3:00 p.m. ET to learn about important updates to CMS's three inpatient pay-for-performance programs, which place up to 6% of a given hospital's inpatient payments at risk in FY 2019.

Register Here


Next in the Daily Briefing

The evidence-backed way to cut harmful medical errors by nearly 40%

Read now